APRIL ROACH: Open Payments
NPI 1851893796 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$200 in 11 payments from 5 companies in 2025. Trend: 2023 $68 · 2024 $65 · 2025 $200
Food & beverage: $200
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 5 | $83 |
| GENZYME CORPORATION | 3 | $48 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $39 |
| HARMONY BIOSCIENCES LLC | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $10 |
Products named: NUCALA, DUPIXENT, LUMRYZ, WAKIX, Sunosi.
Industry payments across LA — which companies pay providers there.
